nodes	percent_of_prediction	percent_of_DWPC	metapath
Bevantolol—ADRB1—stomach cancer	0.525	0.543	CbGaD
Bevantolol—ADRB2—stomach cancer	0.441	0.457	CbGaD
Bevantolol—Esmolol—ADRB1—stomach cancer	0.000849	0.119	CrCbGaD
Bevantolol—Bisoprolol—ADRB1—stomach cancer	0.000722	0.101	CrCbGaD
Bevantolol—Esmolol—ADRB2—stomach cancer	0.000714	0.1	CrCbGaD
Bevantolol—Tamsulosin—HTR1A—stomach cancer	0.000669	0.0939	CrCbGaD
Bevantolol—Bisoprolol—ADRB2—stomach cancer	0.000607	0.0852	CrCbGaD
Bevantolol—Metoprolol—ADRB1—stomach cancer	0.000577	0.081	CrCbGaD
Bevantolol—Carvedilol—VEGFA—stomach cancer	0.000573	0.0803	CrCbGaD
Bevantolol—Metoprolol—ADRB2—stomach cancer	0.000486	0.0681	CrCbGaD
Bevantolol—Propafenone—ADRB1—stomach cancer	0.000426	0.0597	CrCbGaD
Bevantolol—Carvedilol—ADRB1—stomach cancer	0.000383	0.0538	CrCbGaD
Bevantolol—Carvedilol—ADRB2—stomach cancer	0.000322	0.0452	CrCbGaD
Bevantolol—Propranolol—ADRB1—stomach cancer	0.000291	0.0409	CrCbGaD
Bevantolol—Propranolol—HTR1A—stomach cancer	0.000261	0.0366	CrCbGaD
Bevantolol—Propranolol—ADRB2—stomach cancer	0.000245	0.0344	CrCbGaD
Bevantolol—ADRB2—Signaling by GPCR—AGTR2—stomach cancer	2.82e-05	0.00105	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—ADRB1—stomach cancer	2.8e-05	0.00104	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—F2R—stomach cancer	2.79e-05	0.00104	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HTR1A—stomach cancer	2.78e-05	0.00104	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HTR1A—stomach cancer	2.71e-05	0.00101	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKAB1—stomach cancer	2.71e-05	0.00101	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ANXA1—stomach cancer	2.68e-05	0.001	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKAB1—stomach cancer	2.65e-05	0.000988	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ANXA1—stomach cancer	2.62e-05	0.000978	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RNF43—stomach cancer	2.61e-05	0.000975	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KISS1—stomach cancer	2.61e-05	0.000975	CbGpPWpGaD
Bevantolol—ADRB1—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.6e-05	0.00097	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—AGTR2—stomach cancer	2.57e-05	0.000959	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KISS1—stomach cancer	2.56e-05	0.000954	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RNF43—stomach cancer	2.56e-05	0.000954	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—WWOX—stomach cancer	2.55e-05	0.000952	CbGpPWpGaD
Bevantolol—ADRB2—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.54e-05	0.000949	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—F2R—stomach cancer	2.54e-05	0.000948	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—ADRB1—stomach cancer	2.54e-05	0.000948	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—HTR1A—stomach cancer	2.47e-05	0.000923	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ANXA1—stomach cancer	2.39e-05	0.000891	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HRH4—stomach cancer	2.37e-05	0.000885	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—WIF1—stomach cancer	2.37e-05	0.000885	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—AGTR2—stomach cancer	2.33e-05	0.000871	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FST—stomach cancer	2.33e-05	0.000869	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—ADRB2—stomach cancer	2.32e-05	0.000864	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADRB1—stomach cancer	2.31e-05	0.000863	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—F2R—stomach cancer	2.31e-05	0.000861	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HBEGF—stomach cancer	2.28e-05	0.00085	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FST—stomach cancer	2.28e-05	0.00085	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RGS2—stomach cancer	2.25e-05	0.000839	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—GAST—stomach cancer	2.25e-05	0.000839	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HTR1A—stomach cancer	2.25e-05	0.000838	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HBEGF—stomach cancer	2.23e-05	0.000832	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RGS2—stomach cancer	2.2e-05	0.00082	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—GAST—stomach cancer	2.2e-05	0.00082	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKAB1—stomach cancer	2.19e-05	0.000817	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK3—stomach cancer	2.18e-05	0.000814	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ANXA1—stomach cancer	2.17e-05	0.000809	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGG—stomach cancer	2.13e-05	0.000795	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RNF43—stomach cancer	2.11e-05	0.000789	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KISS1—stomach cancer	2.11e-05	0.000789	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—ADRB2—stomach cancer	2.1e-05	0.000785	CbGpPWpGaD
Bevantolol—ADRA1A—Class A/1 (Rhodopsin-like receptors)—CXCL8—stomach cancer	2.1e-05	0.000785	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADRB1—stomach cancer	2.1e-05	0.000784	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGG—stomach cancer	2.08e-05	0.000778	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—MAPK1—stomach cancer	2.08e-05	0.000775	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—stomach cancer	2.08e-05	0.000775	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PPP2R1A—stomach cancer	2.06e-05	0.000769	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKAA1—stomach cancer	2.05e-05	0.000765	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PPP2R1A—stomach cancer	2.02e-05	0.000752	CbGpPWpGaD
Bevantolol—ADRA1A—G alpha (q) signalling events—PIK3CA—stomach cancer	2.01e-05	0.000752	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKAA1—stomach cancer	2.01e-05	0.000749	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RBP4—stomach cancer	1.98e-05	0.000739	CbGpPWpGaD
Bevantolol—ADRB1—GPCR ligand binding—CXCL8—stomach cancer	1.98e-05	0.000739	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—KRAS—stomach cancer	1.96e-05	0.000732	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RBP4—stomach cancer	1.94e-05	0.000723	CbGpPWpGaD
Bevantolol—ADRB2—GPCR ligand binding—CXCL8—stomach cancer	1.94e-05	0.000723	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FST—stomach cancer	1.88e-05	0.000703	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—ADRB2—stomach cancer	1.87e-05	0.000699	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HBEGF—stomach cancer	1.84e-05	0.000688	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RGS2—stomach cancer	1.82e-05	0.000679	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—GAST—stomach cancer	1.82e-05	0.000679	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—stomach cancer	1.8e-05	0.000672	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGG—stomach cancer	1.72e-05	0.000643	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HSPB1—stomach cancer	1.7e-05	0.000636	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AGTR2—stomach cancer	1.7e-05	0.000636	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—ADRB2—stomach cancer	1.7e-05	0.000635	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—BMP2—stomach cancer	1.68e-05	0.000628	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—F2R—stomach cancer	1.68e-05	0.000628	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PPP2R1A—stomach cancer	1.67e-05	0.000622	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—stomach cancer	1.67e-05	0.000622	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HSPB1—stomach cancer	1.67e-05	0.000622	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AGTR2—stomach cancer	1.67e-05	0.000622	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKAA1—stomach cancer	1.66e-05	0.000619	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—AKR1C3—stomach cancer	1.66e-05	0.000618	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—BMP2—stomach cancer	1.65e-05	0.000615	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—F2R—stomach cancer	1.65e-05	0.000615	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HTR1A—stomach cancer	1.64e-05	0.000612	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—AKR1C3—stomach cancer	1.62e-05	0.000605	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HTR1A—stomach cancer	1.6e-05	0.000598	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RBP4—stomach cancer	1.6e-05	0.000598	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR ligand binding—CXCL8—stomach cancer	1.6e-05	0.000598	CbGpPWpGaD
Bevantolol—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—stomach cancer	1.6e-05	0.000595	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PRKCB—stomach cancer	1.59e-05	0.000592	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ANXA1—stomach cancer	1.58e-05	0.000591	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PRKCB—stomach cancer	1.55e-05	0.000579	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ANXA1—stomach cancer	1.55e-05	0.000578	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ADRB1—stomach cancer	1.5e-05	0.00056	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RPS6—stomach cancer	1.47e-05	0.000547	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PRKCB—stomach cancer	1.44e-05	0.000538	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6ST—stomach cancer	1.44e-05	0.000536	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RPS6—stomach cancer	1.43e-05	0.000535	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PRKCB—stomach cancer	1.41e-05	0.000526	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6ST—stomach cancer	1.4e-05	0.000524	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AGTR2—stomach cancer	1.38e-05	0.000514	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HSPB1—stomach cancer	1.38e-05	0.000514	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—BMP2—stomach cancer	1.36e-05	0.000508	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—F2R—stomach cancer	1.36e-05	0.000508	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HBEGF—stomach cancer	1.35e-05	0.000502	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—AKR1C3—stomach cancer	1.34e-05	0.0005	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HTR1A—stomach cancer	1.33e-05	0.000495	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HBEGF—stomach cancer	1.32e-05	0.000491	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PRKCB—stomach cancer	1.28e-05	0.000479	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ANXA1—stomach cancer	1.28e-05	0.000478	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6R—stomach cancer	1.28e-05	0.000478	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—RHOA—stomach cancer	1.27e-05	0.000476	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6R—stomach cancer	1.25e-05	0.000468	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—RHOA—stomach cancer	1.25e-05	0.000465	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ADRB2—stomach cancer	1.24e-05	0.000464	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRB1—stomach cancer	1.24e-05	0.000463	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PPP2R1A—stomach cancer	1.22e-05	0.000454	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PPP2R1A—stomach cancer	1.19e-05	0.000444	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RPS6—stomach cancer	1.19e-05	0.000442	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PRKCB—stomach cancer	1.17e-05	0.000435	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6ST—stomach cancer	1.16e-05	0.000434	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—RHOA—stomach cancer	1.16e-05	0.000432	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—RHOA—stomach cancer	1.13e-05	0.000422	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SMAD4—stomach cancer	1.13e-05	0.000422	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—CXCL8—stomach cancer	1.12e-05	0.000417	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SMAD4—stomach cancer	1.11e-05	0.000413	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—CXCL8—stomach cancer	1.09e-05	0.000408	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HBEGF—stomach cancer	1.09e-05	0.000407	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FYN—stomach cancer	1.07e-05	0.000401	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FYN—stomach cancer	1.05e-05	0.000392	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6R—stomach cancer	1.04e-05	0.000387	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—RHOA—stomach cancer	1.03e-05	0.000385	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—CXCL8—stomach cancer	1.02e-05	0.000379	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—FGFR2—stomach cancer	1.01e-05	0.000376	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ADRB2—stomach cancer	1.01e-05	0.000375	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—CXCL8—stomach cancer	9.94e-06	0.000371	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—FGFR2—stomach cancer	9.86e-06	0.000368	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PPP2R1A—stomach cancer	9.85e-06	0.000368	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—RHOA—stomach cancer	9.36e-06	0.000349	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IRS2—stomach cancer	9.23e-06	0.000344	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SMAD4—stomach cancer	9.15e-06	0.000341	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—CXCL8—stomach cancer	9.05e-06	0.000338	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IRS2—stomach cancer	9.03e-06	0.000337	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CAV1—stomach cancer	8.95e-06	0.000334	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APOA1—stomach cancer	8.93e-06	0.000333	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CAV1—stomach cancer	8.75e-06	0.000327	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APOA1—stomach cancer	8.73e-06	0.000326	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FYN—stomach cancer	8.68e-06	0.000324	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PRKCB—stomach cancer	8.52e-06	0.000318	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6ST—stomach cancer	8.48e-06	0.000317	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PRKCB—stomach cancer	8.33e-06	0.000311	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6ST—stomach cancer	8.3e-06	0.00031	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—CXCL8—stomach cancer	8.22e-06	0.000307	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—FGFR2—stomach cancer	8.15e-06	0.000304	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—APC—stomach cancer	8.15e-06	0.000304	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—APC—stomach cancer	7.97e-06	0.000297	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MAPK3—stomach cancer	7.8e-06	0.000291	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MAPK3—stomach cancer	7.63e-06	0.000285	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6R—stomach cancer	7.57e-06	0.000282	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IRS2—stomach cancer	7.47e-06	0.000279	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—MAPK1—stomach cancer	7.43e-06	0.000277	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—EGFR—stomach cancer	7.42e-06	0.000277	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6R—stomach cancer	7.4e-06	0.000276	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—MAPK1—stomach cancer	7.26e-06	0.000271	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—EGFR—stomach cancer	7.26e-06	0.000271	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CAV1—stomach cancer	7.24e-06	0.00027	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APOA1—stomach cancer	7.22e-06	0.00027	CbGpPWpGaD
Bevantolol—ADRB1—GPCR downstream signaling—PIK3CA—stomach cancer	7.1e-06	0.000265	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—SERPINE1—stomach cancer	7.09e-06	0.000264	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—KRAS—stomach cancer	7.01e-06	0.000262	CbGpPWpGaD
Bevantolol—ADRB2—GPCR downstream signaling—PIK3CA—stomach cancer	6.94e-06	0.000259	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—SERPINE1—stomach cancer	6.93e-06	0.000259	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PRKCB—stomach cancer	6.89e-06	0.000257	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6ST—stomach cancer	6.86e-06	0.000256	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—KRAS—stomach cancer	6.86e-06	0.000256	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—RHOA—stomach cancer	6.84e-06	0.000255	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—NOS3—stomach cancer	6.76e-06	0.000252	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—RHOA—stomach cancer	6.69e-06	0.00025	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—NOS3—stomach cancer	6.62e-06	0.000247	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—APC—stomach cancer	6.59e-06	0.000246	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—PIK3CA—stomach cancer	6.44e-06	0.00024	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—ERBB2—stomach cancer	6.33e-06	0.000236	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAPK3—stomach cancer	6.31e-06	0.000236	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—PIK3CA—stomach cancer	6.3e-06	0.000235	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—ERBB2—stomach cancer	6.19e-06	0.000231	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6R—stomach cancer	6.12e-06	0.000228	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—MAPK1—stomach cancer	6.01e-06	0.000224	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—EGFR—stomach cancer	6.01e-06	0.000224	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CXCL8—stomach cancer	6e-06	0.000224	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—HRAS—stomach cancer	5.96e-06	0.000222	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CXCL8—stomach cancer	5.87e-06	0.000219	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN1B—stomach cancer	5.86e-06	0.000219	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—HRAS—stomach cancer	5.83e-06	0.000218	CbGpPWpGaD
Bevantolol—ADRA1A—GPCR downstream signaling—PIK3CA—stomach cancer	5.74e-06	0.000214	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—SERPINE1—stomach cancer	5.73e-06	0.000214	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN1B—stomach cancer	5.73e-06	0.000214	CbGpPWpGaD
Bevantolol—ADRB1—Signaling by GPCR—IL6—stomach cancer	5.71e-06	0.000213	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—KRAS—stomach cancer	5.67e-06	0.000212	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CCND1—stomach cancer	5.59e-06	0.000209	CbGpPWpGaD
Bevantolol—ADRB2—Signaling by GPCR—IL6—stomach cancer	5.58e-06	0.000208	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—JUN—stomach cancer	5.58e-06	0.000208	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—RHOA—stomach cancer	5.53e-06	0.000206	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—NOS3—stomach cancer	5.47e-06	0.000204	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CCND1—stomach cancer	5.47e-06	0.000204	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—JUN—stomach cancer	5.46e-06	0.000204	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MMP9—stomach cancer	5.43e-06	0.000203	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—CDKN1A—stomach cancer	5.41e-06	0.000202	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MMP9—stomach cancer	5.31e-06	0.000198	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—CDKN1A—stomach cancer	5.29e-06	0.000197	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK8—stomach cancer	5.28e-06	0.000197	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—PIK3CA—stomach cancer	5.21e-06	0.000195	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK8—stomach cancer	5.16e-06	0.000193	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—ERBB2—stomach cancer	5.12e-06	0.000191	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—VEGFA—stomach cancer	4.87e-06	0.000182	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CXCL8—stomach cancer	4.86e-06	0.000181	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—STAT3—stomach cancer	4.83e-06	0.00018	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—HRAS—stomach cancer	4.82e-06	0.00018	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—VEGFA—stomach cancer	4.77e-06	0.000178	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN1B—stomach cancer	4.74e-06	0.000177	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—STAT3—stomach cancer	4.72e-06	0.000176	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling by GPCR—IL6—stomach cancer	4.62e-06	0.000172	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK3—stomach cancer	4.61e-06	0.000172	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CCND1—stomach cancer	4.52e-06	0.000169	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—JUN—stomach cancer	4.51e-06	0.000168	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK3—stomach cancer	4.51e-06	0.000168	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MYC—stomach cancer	4.48e-06	0.000167	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MMP9—stomach cancer	4.39e-06	0.000164	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—MAPK1—stomach cancer	4.39e-06	0.000164	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MYC—stomach cancer	4.39e-06	0.000164	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—EGFR—stomach cancer	4.39e-06	0.000164	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—CDKN1A—stomach cancer	4.38e-06	0.000163	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—MAPK1—stomach cancer	4.29e-06	0.00016	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—EGFR—stomach cancer	4.29e-06	0.00016	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK8—stomach cancer	4.27e-06	0.000159	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—KRAS—stomach cancer	4.14e-06	0.000155	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—KRAS—stomach cancer	4.05e-06	0.000151	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—VEGFA—stomach cancer	3.94e-06	0.000147	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—STAT3—stomach cancer	3.9e-06	0.000146	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—PIK3CA—stomach cancer	3.81e-06	0.000142	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK3—stomach cancer	3.73e-06	0.000139	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—PIK3CA—stomach cancer	3.72e-06	0.000139	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—TP53—stomach cancer	3.68e-06	0.000137	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MYC—stomach cancer	3.63e-06	0.000135	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—TP53—stomach cancer	3.6e-06	0.000134	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—MAPK1—stomach cancer	3.55e-06	0.000132	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—EGFR—stomach cancer	3.55e-06	0.000132	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—HRAS—stomach cancer	3.52e-06	0.000131	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—HRAS—stomach cancer	3.45e-06	0.000129	CbGpPWpGaD
Bevantolol—ADRB1—Signaling Pathways—IL6—stomach cancer	3.37e-06	0.000126	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—KRAS—stomach cancer	3.35e-06	0.000125	CbGpPWpGaD
Bevantolol—ADRB2—Signaling Pathways—IL6—stomach cancer	3.3e-06	0.000123	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—PIK3CA—stomach cancer	3.08e-06	0.000115	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—TP53—stomach cancer	2.98e-06	0.000111	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—HRAS—stomach cancer	2.85e-06	0.000106	CbGpPWpGaD
Bevantolol—ADRA1A—Signaling Pathways—IL6—stomach cancer	2.73e-06	0.000102	CbGpPWpGaD
